Breast Cancer | Medscape

Breast Cancer News

ESTRO Partial-Breast Irradiation Redeemed in European Trial American concerns over increased mastectomy rate are not borne out in European data.
Medscape Medical News, May 15, 2012
ASBS Annual Mammography Adequate After Breast-Conserving Surgery Many protocols call for mammography 6 months after breast-conserving surgery, but low recurrence rates suggest annual imaging is sufficient.
Medscape Medical News, May 11, 2012

The Downside of Chemoprevention for Breast Cancer An analysis of data from the STAR study reveals the gynecologic risks associated with tamoxifen and raloxifene.
Medscape Ob/Gyn, April 26, 2012
Early Reports on T-DM1 Breast Cancer Trial Dr. Kathy Miller comments on early reports that a phase 3 trial of T-DM1 shows "substantially" increased survival in HER2-positive breast cancer patients.
Medscape Hematology-Oncology, April 13, 2012

Does Elevated Risk Require MRI?
Medscape Hematology-Oncology, April 6, 2012
Studies Bolster Arguments for Mammography After Age 40
Medscape Radiology, March 22, 2012
Exemestane Benefit Confirmed
Medscape Hematology-Oncology, March 21, 2012
HER2-Positive Breast Cancer: The Next Testis Cancer?
Medscape Hematology-Oncology, March 16, 2012

Menopausal Hormone Therapy and Breast Cancer
Journal of the National Cancer Institute, May 15, 2012
Eribulin Mesylate for Treatment of Metastatic Breast Cancer
American Journal of Health-System Pharmacy, May 14, 2012
HER2 Gene Amplification in Breast Cancer
American Journal of Clinical Pathology, May 10, 2012
miRNAs in Breast Cancer: Ready for Real Time?
Pharmacogenomics, May 10, 2012
Margin Threshold for Women With Ductal Carcinoma In Situ
Journal of the National Cancer Institute, May 8, 2012